NEW YORK – Clever Leaves (the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its Colombian operations have been named a Project of National and Strategic Interests (“PINE”) by the Government of Colombia. The PINE designation highlights the Colombian government’s continued support of Clever Leaves’ work within the industry, as well as the importance of its economic contributions to Colombia and the growing medical cannabis industry. The PINE designation will offer Clever Leaves accelerated and simplified administrative processes as the Company continues to develop new products and services and bring them to market.
Clever Leaves has worked closely with the Colombian government since inception to commercialize and export high-quality Colombian cannabis, as well as finished and semi-finished medical cannabis products, with a focus on operational sustainability and high production standards. Clever Leaves has received multiple international quality certifications that have enabled it to increase its export capabilities from Colombia, including the first and only Good Manufacturing Practices (GMP) Certification by INVIMA to a cannabis company; Good Agricultural and Collecting Practices (GACP) Certification; and the only European Union Good Manufacturing Practices (EU GMP) Certification for a cannabis company in LATAM.
“The PINE designation is a reflection of our continued efforts to work in partnership with the Colombian government and recognition of the significant contributions to the country’s medical cannabis industry and broader economy. We pride ourselves on creating a business that not only generates a positive return on investment but demonstrates operational sustainability and positively impacts the community in which we operate,” said Kyle Detwiler, CEO of Clever Leaves. “We anticipate the PINE declaration to help streamline processes and coordination with government entities as we work to commercialize Colombian medical cannabis products and respond to evolving industry needs.”
“We appreciate the Colombian government’s identification of Clever Leaves as a leader within the Colombian industry and their support to bring EU-GMP certified cannabis products to patients both domestically and internationally. With this additional government commitment supporting efficient and optimized processes and procedures, Clever Leaves continues to establish Colombia as an epicenter for medical cannabis production, while ensuring that the industry continues to create a significant economic impact on an international and regional level,” said Andrés Fajardo, President of Clever Leaves.
For all business inquiries, please visit Clever Leaves’ direct to business sales platform, www.cleverleaves360.com, to set up an appointment with a Clever Leaves’ business consultant.
Clever Leaves was also recently in the news when they announced a potential business combination with Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and disclosed the signing of a definitive agreement on July 27th. The transaction is expected to close in the fourth quarter of 2020 and the combined company is anticipated to trade on the NASDAQ under the symbol “CLVR”.
About Clever Leaves International Inc.
Clever Leaves is a multi-national cannabinoid company with a mission to operate in compliance with federal and state laws and with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabinoid business. With operations and investments in Canada, Colombia, Germany, Portugal, and the United States, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabinoid companies recognized for its principles, people, and performance while fostering a healthier global community.
About Schultze Special Purpose Acquisition Corp.
Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. SAMA’s sponsor is an affiliate of Schultze Asset Management, LP, an alternative investment management firm founded in 1998 that focuses on distressed, special situation and event-driven securities and has invested over $3.2 billion since inception with a notable track-record through its active investment strategy. SAMA itself is backed by an experienced team of operators and investors with a successful track-record of creating material value in public and private companies.